세계의 싱글 셀 시퀀싱 시장 : 제품별, 용도별, 최종 사용자별 - 예측(2025-2030년)

The Single Cell Sequencing Market was valued at USD 2.52 billion in 2023, expected to reach USD 2.64 billion in 2024, and is projected to grow at a CAGR of 4.87%, to USD 3.51 billion by 2030.

Single cell sequencing (SCS) refers to the process of analyzing the genetic material of individual cells, allowing for a comprehensive understanding of cellular diversity and function. This technology is crucial for identifying rare cell types, understanding disease mechanisms, and expediting personalized medicine approaches. The necessity of SCS is highlighted in its application across oncology, neurology, immunology, and developmental biology, where it aids in the identification of heterogeneous cell populations within tissues. Its end-use scope spans biotechnology firms, academic institutions, and clinical laboratories. The market for single cell sequencing is significantly influenced by advancements in sequencing technologies, decreasing costs, and an increasing emphasis on precision medicine. Opportunities in this market are vast, with potential growth driven by innovations in microfluidics and computational biology to better handle and interpret complex data. There is also a growing opportunity in expanding the use of SCS in clinical diagnostics and drug discovery, particularly in cancer treatment. However, market growth is constrained by challenges such as high initial costs for technology setup and the complexity involved in data analysis. Technical limitations, like low input RNA amounts leading to amplification bias, also pose challenges. Innovation can propel business growth, particularly through the development of more efficient and cost-effective sequencing platforms and robust bioinformatics tools tailored for single cell data. Market players could venture into partnerships with healthcare providers for real-world applications to broaden their impact. As the market is characterized by rapid technological advances and high competition, companies must focus on developing integrated solutions that address both large-scale data management and interpretation to maintain a competitive edge. Ultimately, the pursuit of innovative solutions and strategic collaborations can nurture growth within this dynamic and evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single Cell Sequencing Market

The Single Cell Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic and infectious diseases
  • Rising number of pharmaceutical and biotechnology companies
  • Growth in stem-cell research
• Market Restraints
  • High-cost of single-cell sequencing
• Market Opportunities
  • Ongoing demand for personalized or customized medicine
  • Rising potential of single-cell sequencing and stem cell research
• Market Challenges
  • Difficulty in the measurement of single DNA molecule

Porter's Five Forces: A Strategic Tool for Navigating the Single Cell Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single Cell Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single Cell Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single Cell Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single Cell Sequencing Market

A detailed market share analysis in the Single Cell Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single Cell Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single Cell Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single Cell Sequencing Market

A strategic analysis of the Single Cell Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single Cell Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Becton, Dickinson, and Company, BGI Genomics Co. Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, DNA Electronics Ltd., F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, Mission Bio, Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Qiagen N.V., and Standard BioTools Inc..

Market Segmentation & Coverage

This research report categorizes the Single Cell Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Assay Kits, Beads, and Microplates. The Instruments is further studied across Flow Cytometer, Microarray Systems, Next-Generation Sequencing Systems, and Polymerase Chain Reaction.
• Based on Application, market is studied across Immunology, Microbiology, Neurology, Oncology, and Pre-Natal Diagnosis.
• Based on End-User, market is studied across Biopharmaceutical & Biotech Companies, Hospitals, Clinics, & Diagnostic Labs, and Research & Academic Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic and infectious diseases
    • 5.1.1.2. Rising number of pharmaceutical and biotechnology companies
    • 5.1.1.3. Growth in stem-cell research
  • 5.1.2. Restraints
    • 5.1.2.1. High-cost of single-cell sequencing
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing demand for personalized or customized medicine
    • 5.1.3.2. Rising potential of single-cell sequencing and stem cell research
  • 5.1.4. Challenges
    • 5.1.4.1. Difficulty in the measurement of single DNA molecule
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Single Cell Sequencing Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Assay Kits
  • 6.2.2. Beads
  • 6.2.3. Microplates
• 6.3. Instruments
  • 6.3.1. Flow Cytometer
  • 6.3.2. Microarray Systems
  • 6.3.3. Next-Generation Sequencing Systems
  • 6.3.4. Polymerase Chain Reaction

7. Single Cell Sequencing Market, by Application

• 7.1. Introduction
• 7.2. Immunology
• 7.3. Microbiology
• 7.4. Neurology
• 7.5. Oncology
• 7.6. Pre-Natal Diagnosis

8. Single Cell Sequencing Market, by End-User

• 8.1. Introduction
• 8.2. Biopharmaceutical & Biotech Companies
• 8.3. Hospitals, Clinics, & Diagnostic Labs
• 8.4. Research & Academic Laboratories

9. Americas Single Cell Sequencing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Single Cell Sequencing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Single Cell Sequencing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. Becton, Dickinson, and Company
• 4. BGI Genomics Co. Ltd.
• 5. Bio-Rad Laboratories, Inc.
• 6. Danaher Corporation
• 7. DNA Electronics Ltd.
• 8. F. Hoffmann-La Roche Ltd.
• 9. Illumina, Inc.
• 10. Merck KGaA
• 11. Mission Bio
• 12. Oxford Nanopore Technologies PLC
• 13. PerkinElmer, Inc.
• 14. Qiagen N.V.
• 15. Standard BioTools Inc.